October 12, 2022 —  Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

October 12, 2022 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere,  announced the appointment of Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer. In addition to his world-renowned expertise in interventional cardiology, Dr. Fitzgerald is an accomplished inventor, entrepreneur, and investment fund founder. 

Change Healthcare’s cloud-native archiving, viewing, and image-sharing solutions can help improve efficiencies in cardiovascular imaging, streamline workflows, reduce redundant data entry, and balance workload — all while keeping costs under control.

With up to 14 times faster data transfer, along with limitless, seamlessly scalable cloud storage, we’ll help you reduce TCO, enhance security and business continuity capabilities, and provide full access to the entire patient imaging record in the cloud.

October 11, 2022 — The preliminary results of the first-in-human (FIH) trials for the innovative ELANA Heart Bypass Solution have been unveiled today and look promising. 

October 11, 2022 — Researchers from the University of Minnesota Medical School found that patients with certain features on magnetic resonance imaging (MRI) of the heart are at much higher risk for cardiac sarcoidosis-related adverse outcomes. These patients may benefit from an implantable cardioverter defibrillator.

October 11, 2022 —  Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it has been awarded a Phase II Small Business Innovat

New research shows superiority of Ultromics’ AI in predicting cardiac-related death

October 7, 2022 — A new research grant will enable University of Cincinnati researchers to learn more about how inflammation affects patient recovery after certain kinds of strokes.

October 7, 2022 —  Ultromics, a digital health technology company pioneering the development of transformative heart failure diagnostics, has joined as a full partner The Accelerating Medicines Partnership Heart Failure (AMP HF) including the National Institutes of Health (NIH)

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now